Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Lipid Metabolism in Gestational Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Lipid Metabolism in Gestational Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00534105).
- Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01315236).
- Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LIPSIndependent statistical analysis of A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LIPS-A: Lung Injury Prevention Study With Aspirin: Complete Statistical AnalysisIndependent statistical analysis of LIPS-A: Lung Injury Prevention Study With Aspirin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01504867).
- Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients: Complete Statistical AnalysisIndependent statistical analysis of Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: Complete Statistical AnalysisIndependent statistical analysis of Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006): Complete Statistical AnalysisIndependent statistical analysis of Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03483103).
- Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03036566).
- LittlEarsIndependent statistical analysis of Littlears Auditory Questionnaire: Validation Study in CI Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00785707).
- Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: Complete Statistical AnalysisIndependent statistical analysis of Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LiveWellIndependent statistical analysis of DBT for Metastatic Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04973436).
- LIVIINIndependent statistical analysis of Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Living With Multimorbidity: CO-ORDINATE Program: Complete Statistical AnalysisIndependent statistical analysis of Living With Multimorbidity: CO-ORDINATE Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05985044).
- LLTEVARIndependent statistical analysis of LSA Reconstruction With Laser Fenestration During the TEVAR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03845829).
- Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery May Decrease Pain for Several More Hours: Complete Statistical AnalysisIndependent statistical analysis of Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery May Decrease Pain for Several More Hours: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LOCALIZEIndependent statistical analysis of Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LOGICIndependent statistical analysis of LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LoGoIndependent statistical analysis of Low-dose Gonal-f® in Ovulation Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01871532).
- Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes – a Randomized Pragmatic Trial: Complete Statistical AnalysisIndependent statistical analysis of Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial:…
- Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg): Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen…
- Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: Complete Statistical AnalysisIndependent statistical analysis of Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: primary endpoint results, effect estimate…
- Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex: Complete Statistical AnalysisIndependent statistical analysis of Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) – Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: Complete Statistical AnalysisIndependent statistical analysis of Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Active Surveillance Study for Oral Contraceptives (LASS): Complete Statistical AnalysisIndependent statistical analysis of Long-term Active Surveillance Study for Oral Contraceptives (LASS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00676065).
- Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563): Complete Statistical AnalysisIndependent statistical analysis of Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): Complete Statistical AnalysisIndependent statistical analysis of Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials – ECZTEND: Complete Statistical AnalysisIndependent statistical analysis of Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.: primary endpoint results, effect estimate with confidence…
- Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-Term Immune Persistence of GSK Biologicals’ Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia: Complete Statistical AnalysisIndependent statistical analysis of Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Outcomes After Percutaneous Closure of PFO: Complete Statistical AnalysisIndependent statistical analysis of Long-term Outcomes After Percutaneous Closure of PFO: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05558774).
- Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals’ Hepatitis B Vaccine (HBV), Engerix-B: Complete Statistical AnalysisIndependent statistical analysis of Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-Term Retention of Gadolinium in Bone: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Retention of Gadolinium in Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01853163).
- Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004: Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…